DAX19.060 -0,7%ESt504.751 -0,8%MSCIW3.737 -0,1%Dow43.269 -0,3%Nas18.987 +1,0%Bitcoin87.204 +0,3%Euro1,0588 -0,1%Öl73,30 ±0,0%Gold2.636 +0,2%
Beliebte Suche
DAX 40 Ölpreis Euro - Dollar Bitcoin - Euro Goldpreis
Meistgesucht
NVIDIA 918422 Rheinmetall 703000 Tesla A1CX3T Super Micro Computer A40MRM Bayer BAY001 Palantir A2QA4J MicroStrategy 722713 EVOTEC 566480 Siemens Energy ENER6Y thyssenkrupp 750000 Amazon 906866 Volkswagen (VW) vz. 766403 Coinbase A2QP7J Mercedes-Benz Group (ex Daimler) 710000 RENK RENK73
Alle Aktien für 0 Euro (zzgl. Spreads) handeln mit finanzen.net zero. Hier informieren
Heute im Fokus
DAX beendet Handel knapp über 19.000 Punkten -- US-Börsen uneinheitlich -- thyssenkrupp: Milliardenverlust -- Rivian-CFO will sich von Millionen Rivian-Aktien trennen -- Super Micro, Xpeng im Fokus
Top News
Mehr Flexibilität für Tesla-Fahrer: Ladepunkte von Drittanbietern im Navigationssystem Mehr Flexibilität für Tesla-Fahrer: Ladepunkte von Drittanbietern im Navigationssystem
Trump 2.0: Das könnte jetzt auf Europas Banken zukommen Trump 2.0: Das könnte jetzt auf Europas Banken zukommen
Suche...
Login
ODER

Neu auf finanzen.net?

Kostenfrei registrieren und Vorteile nutzen

Übersicht Wertpapierdepots Musterdepots Watchlists Meine News Newsletter Forum Trading Desk Apps Social Media Podcasts
Profil

Curis Aktie

NeuKaufenVerkaufen
Aktien, ETFs, Sparpläne & Kryptos zu Top-Konditionen beim Testsieger von finanztip.de handeln!
JETZT LOSLEGEN
Bei einem anderen Broker handelnSmartphone

WKNA2JMX7

ISINUS2312692005

SymbolCRIS

Curis Aktien News

DatumMeistgelesen
ZacksCuris (CRIS) Reports Q3 Loss, Tops Revenue Estimates
PR NewswireCuris Provides Third Quarter 2024 Business Update
PR NewswireCuris to Report Third Quarter 2024 Financial and Operating Results and Host Conference Call and Webcast on November 14, 2024
PR NewswireCuris Announces the 3rd Annual Symposium on IRAK4 in Cancer
PR NewswireCuris to Participate at the Upcoming 2024 Cantor Fitzgerald Global Healthcare Conference
PR NewswireCuris to Present at Upcoming Healthcare Conferences in September
ZacksCuris (CRIS) Reports Q2 Loss, Tops Revenue Estimates
PR NewswireCuris Provides Second Quarter 2024 Financial and Operating Update
PR NewswireCuris to Report Second Quarter 2024 Financial and Operating Results and Host Conference Call and Webcast on August 1, 2024
PR NewswireCuris to Present at Upcoming Healthcare Conference in July
ZacksWhat Makes Curis (CRIS) a New Buy Stock
PR NewswireCuris Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
PR NewswireCuris Announces Additional Data from TakeAim Leukemia Study
PR NewswireCuris to Present Updated Data from the TakeAim Leukemia Study
PR NewswireCuris Provides First Quarter 2024 Business Update
PR NewswireCuris to Release First Quarter 2024 Financial Results and Hold Conference Call on May 7, 2024
ZacksStrength Seen in Curis (CRIS): Can Its 19.5% Jump Turn into More Strength?
PR NewswireCuris Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
PR NewswireCuris to Present at Upcoming Healthcare Conferences in April
PR NewswireSHAREHOLDER ALERT: Purcell & Lefkowitz LLP Announces Shareholder Investigation of Curis, Inc. (NASDAQ: CRIS)
PR NewswireCuris Provides Fourth Quarter 2023 Business Update
PR NewswireCuris to Release Fourth Quarter 2023 Financial Results and Hold Conference Call on February 8, 2024
PR NewswireCuris Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
PR NewswireCuris Announces Initial Combination Study Data from its TakeAim Lymphoma Study
PR NewswireCuris Presented Clinical Data from the TakeAim Leukemia Study at the 2023 ASH Conference
PR NewswireCuris Announces Three Presentations at ASH
PR NewswireCuris Enters into Agreement for Emavusertib / Pembrolizumab Combination Study in Melanoma
PR NewswireCuris Provides Third Quarter 2023 Business Update
PR NewswireCuris to Release Third Quarter 2023 Financial Results and Hold Conference Call on November 2, 2023
PR NewswireCuris Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
PR NewswireCuris Announces Date for the 2nd Symposium on IRAK4 in Cancer
PR NewswireCuris to Present at Upcoming Healthcare Conferences in September
PR NewswireCuris Provides Second Quarter 2023 Business Update
PR NewswireCuris to Release Second Quarter 2023 Financial Results and Hold Conference Call on August 3, 2023
PR NewswireFDA Removes Partial Clinical Hold on TakeAim Leukemia Study RP2D Established at 300 mg BID
PR NewswireCuris Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
PR NewswireCuris Provides First Quarter 2023 Business Update
PR NewswireCuris to Release First Quarter 2023 Financial Results and Hold Conference Call on May 4, 2023
PR NewswireCuris Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
PR NewswireCuris to Present at Upcoming Healthcare Conferences in April

Curis News

Curis News: auf dieser Seite finden Sie alle Curis News und Nachrichten zur Curis Aktie. Dies beinhaltet die Agentur-Feeds auf finanzen.net, aber auch Curis News auf einer Vielzahl externer Seiten. Externe Links sind am entsprechenden Link-Symbol zu erkennen. Um Curis News auf externen Seiten zu lesen, folgen Sie einfach dem entsprechenden Link.